• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > Insight on Research > Regulating the disassembly of the eukaryotic DNA replication machinery

Regulating the disassembly of the eukaryotic DNA replication machinery

Published on 26 October, 2021

Chromosome replication is one of the most crucial cellular processes. How the final step of this process – disassembly of the DNA replication machinery, known as the replisome – is regulated has been revealed for the first time

: Image of the replisome with bound ubiquitin ligase targeting the replisome for disassembly.
During termination of DNA replication, association of an E3 ligase (shown in orange) allows replisomes to be marked as ready for disassembly.

Faithful chromosome replication is critical for correct cellular function. Mistakes made during chromosome replication can generate mutations or genome rearrangements that cause genomic instability, leading to the development of cancer. Disassembly of the DNA replication machinery, known as the replisome, is the final step of eukaryotic chromosome replication. Exquisite regulation of this process is essential to ensure that only those replisomes which are no longer active are disassembled, and not those which are mid-way through the process of replicating DNA. Premature removal of the active replisomes would have disastrous consequences, causing DNA replication forks to collapse and leading to under-replication of the genome. Research, by Joe Yeeles’ group in the LMB’s PNAC Division, working with Tom Deegan, at the MRC Protein Phosphorylation and Ubiquitination Unit, Dundee (now at the MRC Human Genetics Unit, Edinburgh), reveals for the first time how replication fork DNA itself regulates replisome disassembly.

Disassembly of the replisome is controlled by a ubiquitin ligase, either SCFDia2 in yeast or CUL2LRR1 in human. Work by Michael Jenkyn-Bedford, in Joe’s group, determined the structures of yeast replisomes bound to SCFDia2, both on double-strand DNA and in the absence of DNA, using electron cryo-microscopy (cryo-EM). Michael’s structures represent the first bona fide replisome disassembly intermediates to be visualised. Then, using the structures to guide mutagenesis experiments, collaborators were able to identify a previously unknown protein-to-protein interaction site between SCFDia2 and the replisome, showing that this structure was essential for replisome disassembly.

Morgan Jones, also in Joe’s group, then determined the structure of a human replisome containing CUL2LRR1. Although Dia2 and LRR1 are not evolutionarily related proteins, Morgan’s structure showed that both bind to exactly the same part of the replisome, at the zinc finger domains of the Mcm3 and Mcm5 subunits. In a separate recent publication (Jones et al., EMBO J, 2021), Morgan has shown that the so-called excluded strand of the replication fork DNA exits the replisome between these zinc finger domains, thereby occupying exactly the same region of the replisome that both Dia2 and LRR1 bind to.

“Remarkably, although the key protein complex that is involved in replisome disassembly is not shared between yeast and human, the mechanism of regulation we have discovered is conserved between the two species, suggesting that it arose by convergent evolution.” – Joe Yeeles.

Figure showing how the double hexamer blocks E3 ligase binding to DNA during replication, preventing the disassembly of the replisome compared to the arrangement when DNA replication is complete and loss of the lagging strand stearic hindrance allows E3 ligase to target the replisome for disassembly.
Cells prevent E3 ligase binding prior to termination in two ways: before the replisome begins unwinding DNA, it forms “double hexamers” where the presence of a second replisome inhibits recruitment of the E3 ligase; subsequently, during active replication, one of the unwound DNA strands is positioned to take over this inhibitory role. Once neither is present post-DNA replication, the E3 ligase can bind to target the replisome for degradation.

Before this research, scientists were aware that replication fork DNA somehow controls the activity of SCFDia2/CUL2LRR1 to restrict Mcm7 modification and, in doing so, the disassembly of the replisome. However, the mechanism by which this is achieved was entirely unknown. Now, this exciting new work sheds light on how the regulation of replisome disassembly is achieved through a simple and conserved mechanism whereby the SCFDia2/CUL2LRR1 binding site, which is essential for replisome ubiquitination, is sterically blocked. By blocking this site until DNA replication is complete, the excluded DNA strand helps to prevent premature replisome disassembly, protecting the cell from genomic instability. By better understanding the process of DNA replication, there is huge potential that research of this kind will be fundamental in developing specific cancer therapeutics.

This work was funded by the UKRI MRC and the Wellcome Trust.

Further references

A Conserved Mechanism for Regulating Replisome Disassembly in Eukaryotes. Jenkyn-Bedford, M., Jones, M.L., Baris, Y., Labib, K. P. M., Cannone, G., Yeeles, J. T. P. and Deegan, T.D. Nature (2021). https://doi.org/10.1038/s41586-021-04145-3
Joe Yeeles’ group
Tom Deegan’s group (MRC Human Genetics Unit)

Previous Insight on Research

Unravelling the replisome: how a molecular machine overcomes obstacles to DNA replication
How replication of DNA is initiated at origins
How does the replisome respond to DNA damage?

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2023 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us